Viviana E Horigian

Associate Professor, Educator Track

Phone:
(305) 243-4305
Locator Code:
D80

 
About
Viviana E. Horigian, MD, MHA, is Associate Professor of the Department of Public Health Sciences at the University of Miami, Miller School of Medicine. She is currently serving as the Director of Public Health Education and as a director of the Americas Initiative for Public Health Innovation.  She is also the Executive director of the Florida Node Alliance of the National Drug Abuse Treatment Clinical Trials Network (CTN) housed at the University of Miami. The Florida Node Alliance is a partnership between is scientists and program leaders at the University of Miami with scientist and practice leaders from community treatment agencies located in Florida, Colorado, North Carolina, Georgia, Massachusetts, Puerto Rico, and the Virgin Islands. As partners scientists and practitioners design and implement and train in interventions for alcohol and drug abuse treatment. Dr. Horigian has contributed to the design and implementation of the trials led by the Florida Node Alliance manages its day to day operations and has more than 15 years of experience in the implementation of multi-site randomized clinical trials. Most of her research within the CTN network has been dedicated to evaluating the effects of a family therapy intervention, Brief Strategic Family Therapy BSFT® for adolescent drug abuse. Dr. Horigian’s research career has been committed to improving practice through the implementation of clinical trials in real-world settings, and more recently in creating the local capacities that would allow the implementation of such trials. She was the Principal Investigator of a technology transfer project that aimed to develop the research infrastructure for the implementation of rigorous randomized clinical trials in Mexico. In this role, she mentored investigators from the National Institute of Psychiatry in Mexico on the design, implementation, safety, and interpretation of the results of RCTs in real-world treatment settings. Due to her work, she received a recognition from the National Institutes of Psychiatry in Mexico for hers and the Florida Node Alliance contributions on the establishment of a Mexican Clinical Trials Network. She has used the same methodology for technology transfer to developing research capacity in Ecuador and Chile. Due to her international leadership, she was honored with the 2015 National Institute on Drug Abuse (NIDA) International Program Award of Excellence. She is a member of the Society of Clinical Trials and the National Hispanic Science Network.